Anti-CD52 therapy of rheumatic diseases: Revisited in the era of immune reset
{{output}}
Alemtuzumab is a humanized monoclonal antibody targeting CD52, a glycosylphosphatidylinositol-anchored surface antigen broadly expressed on lymphocytes and other immune cells. Although currently approved for multiple sclerosis and used in selected transplantat... ...
